GeneFerm Biotechnology (Taiwan) Buy Hold or Sell Recommendation
| 1796 Stock | TWD 65.10 0.10 0.15% |
Assuming the 90 days trading horizon and your highly speculative risk level, our recommendation regarding GeneFerm Biotechnology Co is 'Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell GeneFerm Biotechnology Co given historical horizon and risk tolerance towards GeneFerm Biotechnology. When Macroaxis issues a 'buy' or 'sell' recommendation for GeneFerm Biotechnology Co, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out GeneFerm Biotechnology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as GeneFerm and provide practical buy, sell, or hold advice based on investors' constraints. GeneFerm Biotechnology Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
GeneFerm |
Execute GeneFerm Biotechnology Buy or Sell Advice
The GeneFerm recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on GeneFerm Biotechnology Co. Macroaxis does not own or have any residual interests in GeneFerm Biotechnology Co or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute GeneFerm Biotechnology's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
GeneFerm Biotechnology Trading Alerts and Improvement Suggestions
| About 57.0% of the company shares are owned by insiders or employees |
GeneFerm Biotechnology Returns Distribution Density
The distribution of GeneFerm Biotechnology's historical returns is an attempt to chart the uncertainty of GeneFerm Biotechnology's future price movements. The chart of the probability distribution of GeneFerm Biotechnology daily returns describes the distribution of returns around its average expected value. We use GeneFerm Biotechnology Co price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of GeneFerm Biotechnology returns is essential to provide solid investment advice for GeneFerm Biotechnology.
| Mean Return | 0.04 | Value At Risk | -4.82 | Potential Upside | 2.94 | Standard Deviation | 2.35 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of GeneFerm Biotechnology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
GeneFerm Biotechnology Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to GeneFerm Biotechnology or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that GeneFerm Biotechnology's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a GeneFerm stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.03 | |
β | Beta against Dow Jones | 0.44 | |
σ | Overall volatility | 2.18 | |
Ir | Information ratio | 0.02 |
GeneFerm Biotechnology Volatility Alert
GeneFerm Biotechnology Co currently demonstrates below-average downside deviation. It has Information Ratio of 0.02 and Jensen Alpha of 0.03. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure GeneFerm Biotechnology's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact GeneFerm Biotechnology's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.GeneFerm Biotechnology Fundamentals Vs Peers
Comparing GeneFerm Biotechnology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze GeneFerm Biotechnology's direct or indirect competition across all of the common fundamentals between GeneFerm Biotechnology and the related equities. This way, we can detect undervalued stocks with similar characteristics as GeneFerm Biotechnology or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of GeneFerm Biotechnology's fundamental indicators could also be used in its relative valuation, which is a method of valuing GeneFerm Biotechnology by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare GeneFerm Biotechnology to competition |
| Fundamentals | GeneFerm Biotechnology | Peer Average |
| Return On Equity | 0.12 | -0.31 |
| Return On Asset | 0.0534 | -0.14 |
| Profit Margin | 0.15 % | (1.27) % |
| Operating Margin | 0.17 % | (5.51) % |
| Current Valuation | 2.48 B | 16.62 B |
| Shares Outstanding | 41.46 M | 571.82 M |
| Shares Owned By Insiders | 57.17 % | 10.09 % |
| Price To Earning | 53.28 X | 28.72 X |
| Price To Book | 2.94 X | 9.51 X |
| Price To Sales | 4.16 X | 11.42 X |
| Revenue | 522.33 M | 9.43 B |
| Gross Profit | 192.65 M | 27.38 B |
| EBITDA | 123.07 M | 3.9 B |
| Net Income | 57.41 M | 570.98 M |
| Cash And Equivalents | 619.1 M | 2.7 B |
| Cash Per Share | 15.32 X | 5.01 X |
| Total Debt | 31.25 M | 5.32 B |
| Debt To Equity | 0.72 % | 48.70 % |
| Current Ratio | 1.98 X | 2.16 X |
| Book Value Per Share | 19.62 X | 1.93 K |
| Cash Flow From Operations | 112.23 M | 971.22 M |
| Earnings Per Share | 2.18 X | 3.12 X |
| Number Of Employees | 12 | 18.84 K |
| Beta | 0.89 | -0.15 |
| Market Capitalization | 3.22 B | 19.03 B |
| Total Asset | 1.32 B | 29.47 B |
| Z Score | 61.8 | 8.72 |
| Annual Yield | 0.01 % | |
| Net Asset | 1.32 B |
GeneFerm Biotechnology Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as GeneFerm . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About GeneFerm Biotechnology Buy or Sell Advice
When is the right time to buy or sell GeneFerm Biotechnology Co? Buying financial instruments such as GeneFerm Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having GeneFerm Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Basic Utilities Thematic Idea Now
Basic Utilities
Companies involved in production and distribution of electric, gas, water, and other energy utilities. The Basic Utilities theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Basic Utilities Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for GeneFerm Stock Analysis
When running GeneFerm Biotechnology's price analysis, check to measure GeneFerm Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneFerm Biotechnology is operating at the current time. Most of GeneFerm Biotechnology's value examination focuses on studying past and present price action to predict the probability of GeneFerm Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneFerm Biotechnology's price. Additionally, you may evaluate how the addition of GeneFerm Biotechnology to your portfolios can decrease your overall portfolio volatility.